Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,258.22 -19.29 (-0.37%) Dow
38,385.12 -301.20 (-0.78%) Nasdaq
16,740.34 +5.32 (+0.03%) Bitcoin USD
69,427.61 +1,376.95 (+2.02%) CMC Crypto 200
1,489.39 +21.45 (+1.46%)
NVO Jan 2025 110.000 put
| Previous close | 2.9400 |
| Open | 2.7900 |
| Bid | 2.6200 |
| Ask | 2.7300 |
| Strike | 110.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.7900 - 2.9400 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.2k |
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 3 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate
PR NewswireNovo Nordisk launches national Wegovy® campaign, Power of Wegovy®
Novo Nordisk today launched The Power of Wegovy®, a new national campaign. The campaign aims to educate on the clinical data of Wegovy® (semaglutide) 2.4 mg injection and reflect the collective empowerment people living with obesity can feel when they don't have to manage their weight alone.
ZacksNew to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
